Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function

Phase 4

• Conditions: Coronary Heart Disease; Essential Hypertension
• Interventions: Drug: danshen dripping pill

• Registration Number: NCT01825759
• Lead Sponsor: West China Hospital

Brief Summary

The Impact of Compound danshen dropping pill for coronary heart disease (CHD) heart and artery structure and function in patients with hypertension

Detailed Description

Compound danshen dropping pill for coronary heart disease (CHD) heart and artery structure and function in patients with hypertension.We can accorand the pwv ,IMT and MDA to assess the impact of heart and artery structure and function.

Study Timeline

• Study Start: 2013-01
• Status Verified: 2013-03
• Study First Submitted: 2013-03-26
• Study First Submitted QC: 2013-04-05
• Last Update Submitted: 2013-04-05
• Study First Posted: 2013-04-08
• Last Update Posted: 2013-04-08
• Primary Completion: 2014-12
• Study Completion: 2014-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

coronary heart disease，primary hypertension， -

Exclusion Criteria

secondary hypertension，diabetes mellitus，chronic renal disease，cardiac insufficiency

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
danshen dripping pill	danshen dripping pill	danshen dripping pill 27mg ten pills by mouth every 8 hours for one year

Primary Outcome Measures

Name	Time	Method
Pulse wave velocity	one year

Secondary Outcome Measures

Name	Time	Method
ankle-brachial index	one year

Trial Locations

Locations (1)

West China Hospital; 🇨🇳 Chengdu, Sichuan, China